Atelvia and Acute kidney failure - a phase IV clinical study of FDA data

Summary:

Acute kidney failure is reported as a side effect among people who take Atelvia (risedronate sodium), especially for people who are female, 60+ old, also take Nexium, and have Infection.

The phase IV clinical study analyzes which people have Acute kidney failure when taking Atelvia. It is created by eHealthMe based on reports of 587 people who have side effects when taking Atelvia from the FDA, and is updated regularly.

What is Atelvia?

Atelvia has active ingredients of risedronate sodium. It is often used in osteoporosis. eHealthMe is studying from 611 Atelvia users. Check the latest studies of Atelvia.

What is Acute kidney failure?

Acute kidney failure is found to be associated with 2,836 drugs and 4,493 conditions by eHealthMe. Check the latest studies of Acute kidney failure.

On Jul, 26, 2026

587 people reported to have side effects when taking Atelvia.
Among them, 12 people (2.04%) have Acute kidney failure.

Could Atelvia cause Acute kidney failure?

Among these 12 people:

What is the gender of people who have Acute kidney failure when taking Atelvia? *

female: 100 %
male: 0.0 %

What is the age of people who have Acute kidney failure when taking Atelvia? *

What are other drugs people take besides Atelvia? *

What are other side effects people have besides Acute kidney failure? *

Chronic Kidney Disease: 10 people, 83.33%
Nephrogenic Anaemia (anaemia due to kidney disease): 4 people, 33.33%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 3 people, 25.00%
Renal Injury (kidney injury): 2 people, 16.67%
Pneumonia: 2 people, 16.67%
Weight Decreased: 1 person, 8.33%
Indigestion: 1 person, 8.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 8.33%
Bone Density Decreased: 1 person, 8.33%
Dehydration (dryness resulting from the removal of water): 1 person, 8.33%

What are the existing conditions these people have? *

Pain: 8 people, 66.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 66.67%
Infection: 8 people, 66.67%
Urinary Tract Infection: 7 people, 58.33%
High Blood Pressure: 7 people, 58.33%
Stress And Anxiety: 7 people, 58.33%
Cough: 7 people, 58.33%
Fluid Retention (an abnormal accumulation of fluid in the blood): 7 people, 58.33%
High Blood Cholesterol: 7 people, 58.33%
Inflammation: 7 people, 58.33%

* Approximation only. Some reports may have incomplete information.

Do you take Atelvia and have Acute kidney failure?

- Check whether Acute kidney failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atelvia:

Atelvia (611 reports)

Browse all side effects of Atelvia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acute kidney failure:

Acute kidney failure (2,836 drugs)

Browse all the conditions that are associated with Acute kidney failure:

Acute kidney failure (4,493 conditions)

Related publications that referenced our studies

Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on risedronate sodium (the active ingredients of Atelvia) and Atelvia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.